Anita K. Wagner

Also affiliated with Royal Pharmaceutical Society, Harvard Pilgrim Health Care

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “New-Onset Cancer Cases in FDA's Sentinel System: A Large Distributed System of US Electronic Healthcare Data”.

New-Onset Cancer Cases in FDA's Sentinel System: A Large Distributed System of US Electronic Healthcare Data

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1451

N/A

0DataRank · unranked

0 citations

Anita K. Wagner, Katherine A. McGlynn, Charles E. Leonard, Michael Nguyen, Jacqueline M. Major +1 more

Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis

The Lancet Oncology(2025)10.1016/s1470-2045(25)00329-8

N/A

0DataRank · unranked

9 citations

Dingyi Chen, Mengyuan Fu, Luwen Shi, Huseyin Naci, Anita K. Wagner +3 more